Co-morbidites, CVD and metabolic diseases

ASTHMA_CVDMETABOCOMORB

No definition available.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector

Filter registries None

0

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

0

diagram downward connector

Check minimum number of events None

0

diagram downward connector
ASTHMA_CVDMETABOCOMORB

Extra metadata

First used in FinnGen datafreeze DF2

Similar endpoints

Summary Statistics

Key figures

All Female Male
Number of individuals 130938 55447 75491
Unadjusted prevalence (%) 36.80 27.95 47.97
Mean age at first event (years) 58.00 56.89 58.82

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.05 4.50 [4.22, 4.80] <1e-100 26777
15 years 0.02 3.21 [3.00, 3.44] <1e-100 11704
5 years 0.00 4.57 [4.24, 4.92] <1e-100 5605
1 year 0.00 21.32 [18.71, 24.29] <1e-100 4756

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: ASTHMA_CVDMETABOCOMORB – Co-morbidites, CVD and metabolic diseases
GWS hits:

Survival analyses between endpoints

Plot

before Co-morbidites, CVD and metabolic diseases
after Co-morbidites, CVD and metabolic diseases

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Co-morbidites, CVD and metabolic diseases